In today’s briefing:
- Reliance’s Next Mega Industrial Hub: The Rise of Navi Mumbai
- Transsion (688036 CH): Global No. 4 Smartphone Producer, Revenue Up by 88% YoY in 1Q24
- Coal Is Back – The Real Inconvenient Truth
- Tech Supply Chain Tracker (13-Jun-2024): Sony aims for profit in car camera biz by 2026.
- Beijing Capital International Airport: On Track to Break Even
- i-mobile Co Ltd (6535 JP): Q3 FY07/24 flash update
- Ballys Corp (BALY) – Wednesday, Mar 13, 2024
- Jiangsu Hengrui Medicine (600276.CH) – More Downside Ahead; The Long Logic Doesn’t Exist
- CRE Inc/Japan (3458 JP): Q3 FY07/24 flash update
- Cal-Maine Foods Inc (CALM) – Wednesday, Mar 13, 2024
Reliance’s Next Mega Industrial Hub: The Rise of Navi Mumbai
- Reliance Industries (RIL IN) is developing a new integrated industrial area in Navi Mumbai, part of a global economic hub.
- This project, supported by a 43-year land lease and strategic partnerships, aims to attract global companies, fostering innovation and economic growth in the Fourth Industrial Revolution.
- Reliance’s initiative will significantly boost Navi Mumbai’s attractiveness as an investment destination, driving regional economic growth and employment opportunities.
Transsion (688036 CH): Global No. 4 Smartphone Producer, Revenue Up by 88% YoY in 1Q24
- Transsion is the global No. 4 largest smartphone producer according to IDC.
- In 1Q24, shipments increased by 34% YoY and revenue increased by 88% YoY.
- We see the stock’s upside at 17% and the price target at RMB100.00.
Coal Is Back – The Real Inconvenient Truth
- Increased demand from power plants under construction outside G-7 countries
- There is constrained supply as with many other fossil fuels
- We look at a basket of coal stocks with good balance sheets and increasing production
Tech Supply Chain Tracker (13-Jun-2024): Sony aims for profit in car camera biz by 2026.
- Sony plans to achieve profitability in car camera business by 2026, aiming for 6x growth in the sector.
- Samsung cancels anniversary events to focus on new management plan in response to crisis within the company.
- Taiwan’s passive component makers like Yageo and Ample flourish in AI boom, indicating growth potential in semiconductor industry.
Beijing Capital International Airport: On Track to Break Even
- The worst is behind Beijing Capital International Airport. We believe it is on track to achieve breakeven on quarterly basis in 2H24.
- We see recent parking fee hikes at Daxing Airport as a signal that more will come, which is not in the price and can bring in extra option value.
- Boom-And-Bust in China property sector is behind the airport’s share price cycle. The airport is at the cusp of a steady recovery driving mean reversion of valuation .
i-mobile Co Ltd (6535 JP): Q3 FY07/24 flash update
- i-mobile reported cumulative Q3 FY07/24 revenue of JPY16.3bn (+14.3% YoY), operating profit of JPY3.7bn (+9.2% YoY).
- Consumer Service business cumulative Q3 revenue was JPY14.2bn (+19.4% YoY), with segment profit of JPY3.5bn (+18.9% YoY).
- Online Advertising business cumulative Q3 revenue was JPY2.1bn (-11.8% YoY), with segment profit of JPY316mn (-39.3% YoY).
Ballys Corp (BALY) – Wednesday, Mar 13, 2024
- Bally’s Corporation is undervalued despite insiders recognizing its potential
- Standard General made a buyout offer of $15/share, prompting Bally’s to form a special committee
- The author predicts that Standard General will increase their bid to take Bally’s private, highlighting it as a compelling investment opportunity.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.
Jiangsu Hengrui Medicine (600276.CH) – More Downside Ahead; The Long Logic Doesn’t Exist
- Around RMB5 billion generic drugs would be included in VBP in 2024/2025 (e.g. sevoflurane/Ioversol/butorphanol tartrate). So, the assumption that all the negative effects of VBP have cleared up isn’t correct.
- Hengrui’s innovative drugs would lose growth momentum after they reach peak sales. It’s difficult for Hengrui to maintain its scale expansion or achieve the over 20% YoY revenue growth.
- Hengrui’s PE would fall below 30 (or even below 20) in the future, which means its valuation would start to enter a downward trend. Current high valuation cannot be justified.
CRE Inc/Japan (3458 JP): Q3 FY07/24 flash update
- In cumulative Q3 FY07/24, the company reported sales of JPY30.2bn (-30.0% YoY) and business profit of JPY1.3bn (-80.8% YoY).
- Sales from recurring revenue businesses declined 2.8% YoY to JPY18.3bn, with segment profit falling 7.3% YoY to JPY1.9bn.
- The company revised its FY07/24 year-end dividend forecast to JPY50.00 per share, including a special dividend of JPY24.00.
Cal-Maine Foods Inc (CALM) – Wednesday, Mar 13, 2024
- Cal-Maine Foods (CALM) is a promising long-term investment with potential for around 50% upside
- Stock is currently undervalued due to low historical book multiples and high short interest
- Company has a cost advantage over peers and strong earnings potential, especially in the event of an avian flu outbreak
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.